Literature DB >> 16690522

Procarbazine for non-Hodgkin's lymphoma.

Bassem T Chaar1, Pascale Salem, Paul J Petruska.   

Abstract

Procarbazine hydrochloride is an oral alkylating agent with activity against lymphoma. It is most commonly used in the treatment of Hodgkin's disease. The use of procarbazine-containing chemotherapeutic regimens in non-Hodgkin's lymphoma fell out of favor with the advent of CHOP. We report two patients with relapsed and/or refractory follicular lymphoma that achieved a complete and durable remission with a prolonged course of daily procarbazine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690522     DOI: 10.1080/10428190600591517

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  C-MOPP: the forgotten regimen plus Rituximab for untreated and relapsed follicular lymphoma.

Authors:  Mark J Fesler; Medhat Osman; James Glauber; Paul J Petruska
Journal:  Am J Blood Res       Date:  2011-09-22

2.  Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.

Authors:  Jean-Pierre Armand; Vincent Ribrag; Jean-Luc Harrousseau; Lauren Abrey
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.